Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended ...
Patients on semaglutide ( Ozempic, Wegovy) had a 32% increased relative risk of developing nonarteritic anterior ischemic ...
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...
David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
The shortage of Ozempic and Wegovy has been declared over by the Food and Drug Administration, a change that suggests higher ...